Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a Locations section listing Texas as the study site. Removed the HHS Vulnerability Disclosure footer and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T14:30:56.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The study was terminated after a prespecified futility analysis following enrollment of the first cohort of 10 patients. The page now shows Terminated and removes the Active, not recruiting status, with related date updates.
    Difference
    0.6%
    Check dated 2025-12-09T00:58:12.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision indicator in the page footer now shows v3.3.2 instead of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:52:34.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Removal of the government funding and operating status notice banner. This change does not alter any study data, eligibility criteria, enrollment details, or contact information on the page.
    Difference
    0.4%
    Check dated 2025-11-17T20:04:49.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Minor formatting adjustments and a slightly updated last-updated timestamp are visible; core study content such as title, objectives, eligibility criteria, locations, and schedule appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:43:26.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T04:15:51.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.